Our Mission
The Division of Immunization has as its mission the reduction of morbidity and mortality associated with vaccine-preventable diseases.
Vaccine Updates
In May 2023, the Food and Drug Administration approved the first two vaccines for prevention of RSV lower respiratory tract disease (LRTD) for use in adults aged 60 years and older. On June 21, 2023, the Advisory Committee on Immunization Practices (ACIP) recommended that persons aged 60 years and older may receive a single dose of RSV vaccine based on discussions with their healthcare provider about whether RSV vaccination is right for them. Additionally, on August 3, 2023, ACIP recommended nirsevimab for infants aged 8 months and younger during or entering their first RSV season and for infants and children aged 8–19 months who are at increased risk of severe RSV disease entering their second RSV season. The vaccine should be available in the fall.
On August 30, 2023, federal guidance was provided on the anticipated FDA authorization/approval and ACIP recommendations for COVID-19 vaccine commercial product (2023-2024 COVID-19 Vaccine). Once FDA approved, product may begin shipping out in the fall.
Bridge Access Program – The COVID-19 Vaccine Bridge Access Program is being established to ensure uninsured/underinsured adults will still have access to vaccine once the product is commercialized. The program includes two parts: retail pharmacies and public health (via VFA). You can find more information here.
Do you want a copy of your immunization record?
Request All Other Immunization Records
OR Call 877-VAX-IN-VA
Locate immunization services at the Virginia health department nearest you, Click Here
- Virginia Department of Health Announces Statewide Outbreak of Meningococcal Disease (8/30/2023)
- Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices (8/25/2023)
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices in the United States, 2023–24 Influenza Season (8/25/2023)
- CDC Recommends a Powerful New Tool to Protect Infants from the Leading Cause of Hospitalization (8/3/2023)
- FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants (8/21/2023)
- Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
- Breaking Immunization News
- VDH Flu Standing orders are forthcoming.
- Vaccine Standing Orders for Healthcare Providers – Templates
On July 16, 2013, the Immunization Action Coalition (IAC) launched the Hepatitis B Birth Dose Honor Roll. The Honor Roll recognizes hospitals and birthing centers that have attained high coverage rates for administering hepatitis B vaccine at birth. Congratulations to our Virginia hospitals:
Sentara Northern Virginia Medical Center
Woodbridge, VA
Reported a coverage rate of 96% birth dose rate
7/1/2018 – 6/30/2019 (1st yr honor roll status)
Sentara Princess Anne Hospital
Virginia Beach, VA
Reported a coverage rate of 93% birth dose rate
1/1/2019 – 12/31/2019 (2nd yr honor roll status)
Sentara Norfolk General Hospital
Norfolk, VA
Reported a coverage rate of 93% birth dose rate
1/1/2019 – 12/31/2019 (3rd yr honor roll status)
Sentara Williamsburg Regional Medical Center
Williamsburg, VA
Reported a coverage rate of 92% birth dose rate
1/1/2019 – 12/31/2019 (2nd yr honor roll status)
Learn more about the IAC Birth Dose Initiative,
CLICK HERE!